Acturum Life AB
Records under this name other than the patents Acturum Life AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Acturum Life AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,168,668 | Compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,618,993 | Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 8,859,534 | 2-Carboxamide-7-Piperazinyl-Benzofuran Derivatives Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,859,556 | TRPA1 Receptor Antagonist Lapsed on the fee record Ended Oct 14, 2026 · High confidence | Lapsed on the fee record | Ended Oct 14, 2026 | High confidence |
| US 8,367,676 | 2-Carboxamide-7-Piperazinyl-BENZOFURAN Derivatives 774 Lapsed on the fee record Ended Feb 5, 2025 · High confidence | Lapsed on the fee record | Ended Feb 5, 2025 | High confidence |
| US 9,012,457 | 2-Carboxamide-4-Piperazinyl-BENZOFURAN Derivative Lapsed on the fee record Ended Apr 21, 2023 · High confidence | Lapsed on the fee record | Ended Apr 21, 2023 | High confidence |